Nephros Inc

Nephros Inc

Nephros Inc (NEPH) is a small-cap company operating in the medical technology and filtration space. It develops specialised filtration products used in clinical settings and water purification applications; these products are aimed at reducing contaminants and improving fluid quality for healthcare and industrial customers. With a market capitalisation of about $51.41 million, Nephros is a relatively small issuer and can be subject to greater share-price volatility and liquidity constraints than larger peers. Key points for investors to consider include the company’s product adoption in target markets, regulatory approvals, reimbursement dynamics, and the competitive landscape for medical and water filtration technologies. Financial transparency, cash runway and management execution are also central for smaller companies. This summary is for educational purposes only and is not personal financial advice; investors should do their own research, check the company’s filings and consider their risk tolerance before investing.

Stock Performance Snapshot

Strong Buy

Analyst Rating

Analysts strongly recommend buying Nephros Inc's stock, expecting its price to rise significantly.

Average

Financial Health

Nephros Inc shows moderate revenue and cash flow, but profitability could be improved.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring NEPH

Penny Stocks to Watch

Penny Stocks to Watch

Looking for the next big thing at a small price? This carefully selected group of stocks under $5 has caught the attention of professional hedge funds. These hidden gems might offer significant growth potential for investors willing to take on some risk.

Published: May 27, 2025

Explore Basket

Why You’ll Want to Watch This Stock

📈

Niche filtration demand

Products target clinical and water-purification niches where quality matters; growth depends on adoption and reimbursement, though performance can vary.

🌍

Regulatory and market access

Regulatory approvals and contractual access to hospitals or municipalities are key growth drivers; setbacks or delays can affect prospects.

Small-cap dynamics

With a modest market cap, the stock can swing widely and may have limited liquidity, so consider risk tolerance and diversify accordingly.

Why invest with Nemo?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions